-
1
-
-
0038300741
-
Monitoring of human immunodeficiency virus infection in resource-constrained countries
-
Crowe S, Turnbull S, Oelrichs R, Dunne A: Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis 2003, 37:S25-S35.
-
(2003)
Clin Infect Dis
, vol.37
, pp. S25-S35
-
-
Crowe, S.1
Turnbull, S.2
Oelrichs, R.3
Dunne, A.4
-
2
-
-
33750851598
-
HIV-1 viral load assays for resource-limited settings
-
Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W: HIV-1 viral load assays for resource-limited settings. PLoS Med 2006, 3:e417.
-
(2006)
Plos Med
, vol.3
-
-
Fiscus, S.A.1
Cheng, B.2
Crowe, S.M.3
Demeter, L.4
Jennings, C.5
Miller, V.6
Respess, R.7
Stevens, W.8
-
3
-
-
21844465381
-
Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature
-
Ivers LC, Kendrick D, Doucette K: Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005, 41:217-24.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 217-224
-
-
Ivers, L.C.1
Kendrick, D.2
Doucette, K.3
-
4
-
-
0026570624
-
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects
-
Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA: Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis 1992, 165:105-10.
-
(1992)
J Infect Dis
, vol.165
, pp. 105-110
-
-
Boucher, C.A.1
O'sullivan, E.2
Mulder, J.W.3
Ramautarsing, C.4
Kellam, P.5
Darby, G.6
Lange, J.M.7
Goudsmit, J.8
Larder, B.A.9
-
5
-
-
3843061223
-
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
-
Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, Nguyen DP, Katzenstein D, Fessel WJ: Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy. AIDS 2004, 18:1503-11.
-
(2004)
AIDS
, vol.18
, Issue.11
, pp. 1503
-
-
Kantor, R.1
Shafer, R.W.2
Follansbee, S.3
Taylor, J.4
Shilane, D.5
Hurley, L.6
Nguyen, D.P.7
Katzenstein, D.8
Fessel, W.J.9
-
6
-
-
24144489999
-
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia
-
Napravnik S, Edwards D, Stewart P, Stalzer B, Matteson E, Eron JJ Jr: HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia. J Acquir Immune Defic Syndr 2005, 40:34-40.
-
(2005)
J Acquir Immune Defic Syndr
, vol.40
, pp. 34-40
-
-
Napravnik, S.1
Edwards, D.2
Stewart, P.3
Stalzer, B.4
Matteson, E.5
Eron, J.J.6
-
7
-
-
33749628551
-
Quantification of HIV-1 p24 by a highly improved ELISA: An alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Cote d'Ivoire
-
Tehe A, Maurice C, Hanson DL, Borget MY, Abiola N, Maran M, Yavo D, Tomasik Z, Boni J, Schupbach J, Nkengasong JN: Quantification of HIV-1 p24 by a highly improved ELISA: An alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Cote d'Ivoire. J Clin Virol 2006, 37:199-205.
-
(2006)
J Clin Virol
, vol.37
, pp. 199-205
-
-
Tehe, A.1
Maurice, C.2
Hanson, D.L.3
Borget, M.Y.4
Abiola, N.5
Maran, M.6
Yavo, D.7
Tomasik, Z.8
Boni, J.9
Schupbach, J.10
Nkengasong, J.N.11
-
8
-
-
24044469077
-
Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa
-
Lombart JP, Vray M, Kafando A, Lemee V, Ouedraogo-Traore R, Corrigan GE, Plantier JC, Simon F, Braun J: Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa. AIDS 2005, 19:1273-77.
-
(2005)
AIDS
, vol.19
, pp. 1273-1277
-
-
Lombart, J.P.1
Vray, M.2
Kafando, A.3
Lemee, V.4
Ouedraogo-Traore, R.5
Corrigan, G.E.6
Plantier, J.C.7
Simon, F.8
Braun, J.9
-
9
-
-
36549088200
-
Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda
-
Waters L, Kambugu A, Tibenderana H, Meya D, John L, Mandalia S, Nabankema M, Namugga I, Quinn TC, Gazzard B, Reynolds SJ, Nelson M: Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2007, 46:590-593.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 590-593
-
-
Waters, L.1
Kambugu, A.2
Tibenderana, H.3
Meya, D.4
John, L.5
Mandalia, S.6
Nabankema, M.7
Namugga, I.8
Quinn, T.C.9
Gazzard, B.10
Reynolds, S.J.11
Nelson, M.12
-
10
-
-
23744447039
-
Simultaneous visual detection of multiple viral amplicons by dipstick assay
-
Dineva MA, Candotti D, Fletcher-Brown F, Allain JP, Lee H: Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 2005, 43:4015-21.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 4015-4021
-
-
Dineva, M.A.1
Candotti, D.2
Fletcher-Brown, F.3
Allain, J.P.4
Lee, H.5
-
11
-
-
16244370393
-
Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-
-
Ondoa P, Koblavi-Deme S, Borget MY, Nolan ML, Nkengasong JN, Kestens L: Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire. Clin Exp Immunol 2005, 140:138-48.
-
(2005)
Clin Exp Immunol
, vol.140
, Issue.1
, pp. 138-148
-
-
Ondoa, P.1
Koblavi-Deme, S.2
Borget, M.Y.3
Nolan, M.L.4
Nkengasong, J.N.5
Kestens, L.6
-
12
-
-
53549099373
-
Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa
-
Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD: Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008, 22:1971-77.
-
(2008)
AIDS
, vol.22
, pp. 1971-1977
-
-
Mee, P.1
Fielding, K.L.2
Charalambous, S.3
Churchyard, G.J.4
Grant, A.D.5
-
13
-
-
33746780699
-
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
-
Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N: Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS 2006, 20:1613-19.
-
(2006)
AIDS
, vol.20
, pp. 1613-1619
-
-
Bisson, G.P.1
Gross, R.2
Strom, J.B.3
Rollins, C.4
Bellamy, S.5
Weinstein, R.6
Friedman, H.7
Dickinson, D.8
Frank, I.9
Strom, B.L.10
Gaolathe, T.11
Ndwapi, N.12
-
14
-
-
33745218928
-
Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings
-
Lawn SD, Orrell C, Wood R: Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings. Lancet Infect Dis 2006, 6:385-86.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 385-386
-
-
Lawn, S.D.1
Orrell, C.2
Wood, R.3
-
15
-
-
44449123557
-
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
-
Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB: Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med 2008, 5:e109.
-
(2008)
Plos Med
, vol.5
-
-
Bisson, G.P.1
Gross, R.2
Bellamy, S.3
Chittams, J.4
Hislop, M.5
Regensberg, L.6
Frank, I.7
Maartens, G.8
Nachega, J.B.9
-
16
-
-
29244432755
-
A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries
-
Colebunders R, Moses KR, Laurence J, Shihab HM, Semitala F, Lutwama F, Bakeera-Kitaka S, Lynen L, Spacek L, Reynolds SJ, Quinn TC, Viner B, Mayanja-Kizza H: A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis 2006, 6:53-59.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 53-59
-
-
Colebunders, R.1
Moses, K.R.2
Laurence, J.3
Shihab, H.M.4
Semitala, F.5
Lutwama, F.6
Bakeera-Kitaka, S.7
Lynen, L.8
Spacek, L.9
Reynolds, S.J.10
Quinn, T.C.11
Viner, B.12
Mayanja-Kizza, H.13
-
17
-
-
85044324632
-
-
World Health Organisation: Antiretroviral therapy for adults and adolescents in resource-limited settings: towards universal access – Recommendations for a public health approach.,. (2006 revision)
-
World Health Organisation: Antiretroviral therapy for adults and adolescents in resource-limited settings: towards universal access – Recommendations for a public health approach. [http://www.who.int/hiv/pub/guidelines/adult/en/index.html]. (2006 revision)
-
-
-
-
18
-
-
85044303989
-
-
The Infectious Diseases Institute, Makerere University [http://www.idi.ac.ug/]
-
Makerere University
-
-
-
19
-
-
0001696152
-
Wu AW: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)
-
Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000, 12:255-66.
-
(2000)
AIDS Care
, vol.12
, pp. 255-266
-
-
Chesney, M.A.1
Ickovics, J.R.2
Chambers, D.B.3
Gifford, A.L.4
Neidig, J.5
Zwickl, B.6
-
20
-
-
3342913622
-
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting
-
Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR: Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004, 36:1100-1102.
-
(2004)
J Acquir Immune Defic Syndr
, vol.36
, pp. 1100-1102
-
-
Oyugi, J.H.1
Byakika-Tusiime, J.2
Charlebois, E.D.3
Kityo, C.4
Mugerwa, R.5
Mugyenyi, P.6
Bangsberg, D.R.7
-
21
-
-
0037169259
-
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
-
Walsh JC, Mandalia S, Gazzard BG: Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002, 16:269-77.
-
(2002)
AIDS
, vol.16
, pp. 269-277
-
-
Walsh, J.C.1
Mandalia, S.2
Gazzard, B.G.3
-
22
-
-
33750630109
-
Update of the drug resistance mutations in HIV-1: Fall 2006
-
Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD: Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med 2006, 14:125-30.
-
(2006)
Top HIV Med
, vol.14
, pp. 125-130
-
-
Johnson, V.A.1
Brun-Vezinet, F.2
Clotet, B.3
Kuritzkes, D.R.4
Pillay, D.5
Schapiro, J.M.6
Richman, D.D.7
-
23
-
-
53349171968
-
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
-
Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR: CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis 2008, 47:1093-101.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1093-1101
-
-
Khanna, N.1
Opravil, M.2
Furrer, H.3
Cavassini, M.4
Vernazza, P.5
Bernasconi, E.6
Weber, R.7
Hirschel, B.8
Battegay, M.9
Kaufmann, G.R.10
-
24
-
-
33745034347
-
Are the best antiretrovirals being used in Africa?
-
John L, Kambugu A, Songa PM, Castelnuovo B, Colebunders R, Kamya M: Are the best antiretrovirals being used in Africa? J HIV Ther 2006, 11:11-15.
-
(2006)
J HIV Ther
, vol.11
, pp. 11-15
-
-
John, L.1
Kambugu, A.2
Songa, P.M.3
Castelnuovo, B.4
Colebunders, R.5
Kamya, M.6
-
25
-
-
15044352285
-
Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis
-
Nieuwkerk PT, Oort FJ: Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr 2005, 38:445-48.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 445-448
-
-
Nieuwkerk, P.T.1
Oort, F.J.2
-
26
-
-
34247571878
-
Treatment interruptions predict resistance in HIV-positive individuals pur- chasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
-
Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR: Treatment interruptions predict resistance in HIV-positive individuals pur- chasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007, 21:965-71.
-
(2007)
AIDS
, vol.21
, pp. 965-971
-
-
Oyugi, J.H.1
Byakika-Tusiime, J.2
Ragland, K.3
Laeyendecker, O.4
Mugerwa, R.5
Kityo, C.6
Mugyenyi, P.7
Quinn, T.C.8
Bangsberg, D.R.9
-
27
-
-
2342589337
-
Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy
-
Parienti JJ, Massari V, Descamps D, Vabret A, Bouvet E, Larouze B, Verdon R: Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 2004, 38:1311-16.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 1311-1316
-
-
Parienti, J.J.1
Massari, V.2
Descamps, D.3
Vabret, A.4
Bouvet, E.5
Larouze, B.6
Verdon, R.7
-
28
-
-
0034604276
-
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
-
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21-30.
-
(2000)
Ann Intern Med
, vol.133
, pp. 21-30
-
-
Paterson, D.L.1
Swindells, S.2
Mohr, J.3
Brester, M.4
Vergis, E.N.5
Squier, C.6
Wagener, M.M.7
Singh, N.8
-
29
-
-
30144443728
-
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda
-
Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC: Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis 2006, 42:252-59.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 252-259
-
-
Spacek, L.A.1
Shihab, H.M.2
Kamya, M.R.3
Mwesigire, D.4
Ronald, A.5
Mayanja, H.6
Moore, R.D.7
Bates, M.8
Quinn, T.C.9
-
30
-
-
10944238468
-
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death
-
Kitahata MM, Reed SD, Dillingham PW, van Benthem BH, Young AA, Harrington RD, Holmes KK: Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS 2004, 15:803-10.
-
(2004)
Int J STD AIDS
, vol.15
, pp. 803-810
-
-
Kitahata, M.M.1
Reed, S.D.2
Dillingham, P.W.3
van Benthem, B.H.4
Young, A.A.5
Harrington, R.D.6
Holmes, K.K.7
-
31
-
-
33749641642
-
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
-
Gross R, Yip B, Lo RV III, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JS, Hogg RS: A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006, 194:1108-14.
-
(2006)
J Infect Dis
, vol.194
, pp. 1108-1114
-
-
Gross, R.1
Yip, B.2
Lo, R.V.3
Wood, E.4
Alexander, C.S.5
Harrigan, P.R.6
Bangsberg, D.R.7
Montaner, J.S.8
Hogg, R.S.9
-
33
-
-
33750953470
-
Performance of immunologic responses in predicting viral load suppression: Implications for monitoring patients in resource-limited settings
-
Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS: Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr 2006, 43:436-39.
-
(2006)
J Acquir Immune Defic Syndr
, vol.43
, pp. 436-439
-
-
Moore, D.M.1
Mermin, J.2
Awor, A.3
Yip, B.4
Hogg, R.S.5
Montaner, J.S.6
-
34
-
-
4344585725
-
The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment
-
Florence E, Dreezen C, Schrooten W, Van EM, Kestens L, Fransen K, De RA, Colebunders R: The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. Int J STD AIDS 2004, 15:538-42.
-
(2004)
Int J STD AIDS
, vol.15
, pp. 538-542
-
-
Florence, E.1
Dreezen, C.2
Schrooten, W.3
Van, E.M.4
Kestens, L.5
Fransen, K.6
De, R.A.7
Colebunders, R.8
-
35
-
-
0027958415
-
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring
-
Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA: Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994, 169:28-36.
-
(1994)
J Infect Dis
, vol.169
, pp. 28-36
-
-
Hughes, M.D.1
Stein, D.S.2
Gundacker, H.M.3
Valentine, F.T.4
Phair, J.P.5
Volberding, P.A.6
-
36
-
-
85044289158
-
-
US Department of Health and Human Services: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
-
US Department of Health and Human Services: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 2008. [http://aidsinfo.nih.gov/Guidelines/Default.aspx?MenuItem=Guidelines].
-
(2008)
-
-
-
37
-
-
33845686172
-
HIV viral load monitoring in resource-limited regions: Optional or necessary?
-
Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia dl V, Perrin L, Rodriguez W: HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis 2007, 44:128-34.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 128-134
-
-
Calmy, A.1
Ford, N.2
Hirschel, B.3
Reynolds, S.J.4
Lynen, L.5
Goemaere, E.6
Garcia Dl, V.7
Perrin, L.8
Rodriguez, W.9
-
38
-
-
33645830940
-
HIV-1 viral load blips are of limited clinical significance
-
Lee PK, Kieffer TL, Siliciano RF, Nettles RE: HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother 2006, 57:803-5.
-
(2006)
J Antimicrob Chemother
, vol.57
, Issue.5
, pp. 803
-
-
Lee, P.K.1
Kieffer, T.L.2
Siliciano, R.F.3
Nettles, R.E.4
-
39
-
-
0037013040
-
Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy
-
Aleman S, Soderbarg K, Visco-Comandini U, Sitbon G, Sonnerborg A: Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. AIDS 2002, 16:1039-44.
-
(2002)
AIDS
, vol.16
, pp. 1039-1044
-
-
Aleman, S.1
Soderbarg, K.2
Visco-Comandini, U.3
Sitbon, G.4
Sonnerborg, A.5
-
40
-
-
2342591920
-
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
-
Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG: Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS 2004, 18:981-89.
-
(2004)
AIDS
, vol.18
, pp. 981-989
-
-
Karlsson, A.C.1
Younger, S.R.2
Martin, J.N.3
Grossman, Z.4
Sinclair, E.5
Hunt, P.W.6
Hagos, E.7
Nixon, D.F.8
Deeks, S.G.9
-
41
-
-
0035806769
-
Preventing antiretroviral anarchy in sub-Saharan Africa
-
Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001, 358:410-414.
-
(2001)
Lancet
, vol.358
, pp. 410-414
-
-
Harries, A.D.1
Nyangulu, D.S.2
Hargreaves, N.J.3
Kaluwa, O.4
Salaniponi, F.M.5
-
42
-
-
33748108796
-
Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-
-
Koizumi Y, Ndembi N, Miyashita M, Lwembe R, Kageyama S, Mbanya D, Kaptue L, Numazaki K, Fujiyama Y, Ichimura H: Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. J Acquir Immune Defic Syndr 2006, 43:15-22.
-
(2006)
J Acquir Immune Defic Syndr
, vol.43
, Issue.1
, pp. 15-22
-
-
Koizumi, Y.1
Ndembi, N.2
Miyashita, M.3
Lwembe, R.4
Kageyama, S.5
Mbanya, D.6
Kaptue, L.7
Numazaki, K.8
Fujiyama, Y.9
Ichimura, H.10
-
43
-
-
33646871809
-
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: Multicentric observational cohort
-
Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L: Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006, 20:1163-69.
-
(2006)
AIDS
, vol.20
, pp. 1163-1169
-
-
Calmy, A.1
Pinoges, L.2
Szumilin, E.3
Zachariah, R.4
Ford, N.5
Ferradini, L.6
-
44
-
-
2142764446
-
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
-
Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E: Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004, 18:887-95.
-
(2004)
AIDS
, vol.18
, pp. 887-895
-
-
Coetzee, D.1
Hildebrand, K.2
Boulle, A.3
Maartens, G.4
Louis, F.5
Labatala, V.6
Reuter, H.7
Ntwana, N.8
Goemaere, E.9
-
45
-
-
24144487126
-
Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: A preliminary report on the Nigerian antiretroviral program
-
Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, Onwujekwe DI, Audu RA, Araoyinbo ID, Onyewuche JI, Salu OB, Adedoyin JA, Musa AZ: Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. J Acquir Immune Defic Syndr 2005, 40:65-69.
-
(2005)
J Acquir Immune Defic Syndr
, vol.40
, pp. 65-69
-
-
Idigbe, E.O.1
Adewole, T.A.2
Eisen, G.3
Kanki, P.4
Odunukwe, N.N.5
Onwujekwe, D.I.6
Audu, R.A.7
Araoyinbo, I.D.8
Onyewuche, J.I.9
Salu, O.B.10
Adedoyin, J.A.11
Musa, A.Z.12
-
46
-
-
3042698158
-
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial
-
Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liegeois F, Nerrienet E, Tardy M, Peeters M, ndrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngole E, Delaporte E: Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004, 364:29-34.
-
(2004)
Lancet
, vol.364
, pp. 29-34
-
-
Laurent, C.1
Kouanfack, C.2
Koulla-Shiro, S.3
Nkoue, N.4
Bourgeois, A.5
Calmy, A.6
Lactuock, B.7
Nzeusseu, V.8
Mougnutou, R.9
Peytavin, G.10
Liegeois, F.11
Nerrienet, E.12
Tardy, M.13
Peeters, M.14
Ndrieux-Meyer, I.15
Zekeng, L.16
Kazatchkine, M.17
Mpoudi-Ngole, E.18
Delaporte, E.19
-
48
-
-
34249992820
-
The cost effectiveness of antiretroviral treatment strategies in resource-limited settings
-
Bishai D, Colchero A, Durack DT: The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. AIDS 2007, 21:1333-40.
-
(2007)
AIDS
, vol.21
, pp. 1333-1340
-
-
Bishai, D.1
Colchero, A.2
Durack, D.T.3
|